# Ladder Capital Corp: financial statements, quarterly

LADR · NYSE · CIK 1577670 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ladr.md) · [Financials](/companies/ladr/financials.md) · [Filings](/companies/ladr/filings.md) · [Insiders](/companies/ladr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ladr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [62.3](/filings/0001577670-23-000027.md) | [60.7 d](/filings/0001577670-24-000006.md) | [58.8](/filings/0001577670-24-000024.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.1](/filings/0001577670-24-000039.md) | [(0.7) d](/filings/0001577670-26-000011.md) | [1.9](/filings/0001577670-25-000024.md) | [(1.1)](/filings/0001577670-25-000029.md) | [0.9](/filings/0001577670-25-000041.md) | [1.7 d](/filings/0001577670-26-000011.md) | [(0.8)](/filings/0001577670-26-000026.md) | [3.7](/filings/0001577670-26-000040.md) | [1.0](/filings/0001577670-25-000041.md) | [(0.3) d](/filings/0001577670-26-000011.md) | [0.6](/filings/0001577670-26-000026.md) | [1.7](/filings/0001577670-26-000040.md) |
| Net income | $m | [31.2](/filings/0001577670-24-000039.md) | [19.0 d](/filings/0001577670-26-000011.md) | [16.4](/filings/0001577670-25-000024.md) | [32.1](/filings/0001577670-25-000029.md) | [27.6](/filings/0001577670-25-000041.md) | [31.3 d](/filings/0001577670-26-000011.md) | [11.6](/filings/0001577670-26-000026.md) | [17.1](/filings/0001577670-26-000040.md) | [19.2](/filings/0001577670-25-000041.md) | [15.9 d](/filings/0001577670-26-000011.md) | [2.6](/filings/0001577670-26-000026.md) | [14.6](/filings/0001577670-26-000040.md) |
| Diluted EPS | $ per share | [0.25](/filings/0001577670-24-000039.md) | not reported | [0.13](/filings/0001577670-25-000024.md) | [0.26](/filings/0001577670-25-000029.md) | [0.22](/filings/0001577670-25-000041.md) | not reported | [0.09](/filings/0001577670-26-000026.md) | [0.14](/filings/0001577670-26-000040.md) | [0.15](/filings/0001577670-25-000041.md) | not reported | [0.02](/filings/0001577670-26-000026.md) | [0.12](/filings/0001577670-26-000040.md) |
| Basic EPS | $ per share | [0.25](/filings/0001577670-24-000039.md) | not reported | [0.13](/filings/0001577670-25-000024.md) | [0.26](/filings/0001577670-25-000029.md) | [0.22](/filings/0001577670-25-000041.md) | not reported | [0.09](/filings/0001577670-26-000026.md) | [0.14](/filings/0001577670-26-000040.md) | [0.15](/filings/0001577670-25-000041.md) | not reported | [0.02](/filings/0001577670-26-000026.md) | [0.12](/filings/0001577670-26-000040.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [798](/filings/0001577670-24-000039.md) | [1,016](/filings/0001577670-26-000011.md) | [1,220](/filings/0001577670-25-000024.md) | [1,196](/filings/0001577670-25-000029.md) | [1,607](/filings/0001577670-25-000041.md) | [1,323](/filings/0001577670-26-000011.md) | [480](/filings/0001577670-26-000026.md) | [135](/filings/0001577670-26-000040.md) | [49.4](/filings/0001577670-25-000041.md) | [38.0](/filings/0001577670-26-000040.md) | [33.1](/filings/0001577670-26-000026.md) | [37.6](/filings/0001577670-26-000040.md) |
| Total assets | $m | [5,503](/filings/0001577670-23-000027.md) | [5,513](/filings/0001577670-26-000011.md) | [5,323](/filings/0001577670-24-000024.md) | [4,845](/filings/0001577670-25-000029.md) | [4,845](/filings/0001577670-25-000041.md) | [4,845](/filings/0001577670-26-000011.md) | [5,153](/filings/0001577670-26-000026.md) | [4,457](/filings/0001577670-25-000029.md) | [4,687](/filings/0001577670-25-000041.md) | [5,153](/filings/0001577670-26-000040.md) | [5,607](/filings/0001577670-26-000026.md) | [5,606](/filings/0001577670-26-000040.md) |
| Total liabilities | $m | [3,965](/filings/0001577670-23-000027.md) | [3,980](/filings/0001577670-25-000010.md) | [3,799](/filings/0001577670-24-000024.md) | [3,520](/filings/0001577670-24-000032.md) | [3,848](/filings/0001577670-24-000039.md) | [3,312](/filings/0001577670-26-000011.md) | [2,956](/filings/0001577670-25-000024.md) | [2,957](/filings/0001577670-25-000029.md) | [3,193](/filings/0001577670-25-000041.md) | [3,671](/filings/0001577670-26-000040.md) | [4,162](/filings/0001577670-26-000026.md) | [4,180](/filings/0001577670-26-000040.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,539](/filings/0001577670-23-000027.md) | [1,533](/filings/0001577670-25-000010.md) | [1,525](/filings/0001577670-24-000024.md) | [1,530](/filings/0001577670-24-000032.md) | [1,533](/filings/0001577670-24-000039.md) | [1,535](/filings/0001577670-26-000011.md) | [1,517](/filings/0001577670-25-000024.md) | [1,503](/filings/0001577670-25-000029.md) | [1,496](/filings/0001577670-25-000041.md) | [1,484](/filings/0001577670-26-000040.md) | [1,447](/filings/0001577670-26-000026.md) | [1,429](/filings/0001577670-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [78.1 d](/filings/0001577670-24-000039.md) | [58.4 d](/filings/0001577670-26-000011.md) | [(20.4)](/filings/0001577670-25-000024.md) | [45.4 d](/filings/0001577670-25-000029.md) | [169 d](/filings/0001577670-25-000041.md) | [(60.1) d](/filings/0001577670-26-000011.md) | [(28.7)](/filings/0001577670-26-000026.md) | [44.0 d](/filings/0001577670-26-000040.md) | [26.3 d](/filings/0001577670-25-000041.md) | [45.4 d](/filings/0001577670-26-000011.md) | [(8.0)](/filings/0001577670-26-000026.md) | [39.3 d](/filings/0001577670-26-000040.md) |
| Share repurchases | $m | [0.2 d](/filings/0001577670-24-000039.md) | [0.0 d](/filings/0001577670-26-000011.md) | [0.6](/filings/0001577670-25-000024.md) | [0.2 d](/filings/0001577670-25-000029.md) | [1.2 d](/filings/0001577670-25-000041.md) | [4.5 d](/filings/0001577670-26-000011.md) | [2.3](/filings/0001577670-26-000026.md) | [6.6 d](/filings/0001577670-26-000040.md) | [1.5 d](/filings/0001577670-25-000041.md) | [1.3 d](/filings/0001577670-26-000011.md) | [13.4](/filings/0001577670-26-000026.md) | [7.8 d](/filings/0001577670-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [125](/filings/0001577670-23-000027.md) | [125](/filings/0001577670-24-000024.md) | [125](/filings/0001577670-24-000032.md) | [125](/filings/0001577670-24-000039.md) | [126](/filings/0001577670-25-000024.md) | [126](/filings/0001577670-25-000029.md) | [126](/filings/0001577670-25-000041.md) | [126](/filings/0001577670-26-000026.md) | [126](/filings/0001577670-26-000040.md) | [126](/filings/0001577670-25-000041.md) | [126](/filings/0001577670-26-000026.md) | [125](/filings/0001577670-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.